Product Reports Resources Pricing Login Book a demo

Enveda Biosciences

Biotech & Life Sciences · Boulder, United States · Founded 2019

Engineering new drugs from nature with knowledge graphs, metabolomics, and ML

Valuation $1–2.5B
Headcount 100–500
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Enveda Biosciences and the history behind them.
Power Law Unicorn$1–10B valuation tier

Talent graph

Enveda Biosciences's talent

Book a demo to see the people
Employees mapped 392 incl. 17 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 19 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

28 investors on Enveda Biosciences's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 4 investors entered at this stage
Village Global
True Ventures
Chris Gibson
Wireframe Ventures
Series A 6 investors entered at this stage
Lifeforce Capital
Catalio Capital Management
Two Sigma Ventures
Hummingbird Ventures
Lux Capital
Matthew De Silva
Series B+ 18 investors entered at this stage
Lingotto Investment Management
Henry Kravis
Premji Invest
Microsoft
Dimension
Amino Collective
Level Ventures
FPV Ventures
JAZZ Venture Partners
Baillie Gifford
Peakline Partners
Sanofi
Kinnevik
Socium Ventures
IA Ventures
The Nature Conservancy
University of California
San Diego

Ownership

Who owns Enveda Biosciences

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.

13% Kinnevik
  • Kinnevik 13%

Some investors are hidden on this public profile. See the full cap table on Dealroom →

Global footprint

Where Enveda Biosciences has talent and traffic

Workforce by country
8 countries with
team presence
🇺🇸 United States50.6%
🇮🇳 India43.6%
🇨🇦 Canada2.8%
🇩🇪 Germany0.8%
🇬🇧 United Kingdom0.6%
Top 5 of 8 shown
Web traffic by country
28K monthly visits
across markets
🇺🇸 United States82.9%
🇮🇳 India8.2%
🇬🇧 United Kingdom4.6%
🇨🇦 Canada2.1%
🇨🇭 Switzerland1.8%
Top 5 markets shown

Patent intelligence

$206k patent portfolio · 6 active families

Estimated portfolio value
$206k
0.02% of valuation · 194.9× smaller than top peer Caris Life Sciences ($40M)
6 active patent families

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Enveda Biosciences

An AI-synthesized read of the highest-engagement posts about Enveda Biosciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Enveda Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles